The specific role of TCF2 methylation in the development and progression of ovarian cancer remains unknown, but TCF2 mutations are known to affect expression of downstream genes such as HNF4α, PKHD1 and UMOD (Tanaka et al, 2004; Rebouissou et al, 2005). This evidence concerns the gene HNF1B and ovarian cancer.